Regenerative medicine

The translation of stem cell and related technologies into effective regenerative medicine presents huge challenges to researchers, businesses and clinicians. 

The IP space in this market is complex, crowded, proliferated and fragmented, with a path leading towards intricate royalty provisions and patent conflict. The need for commercial investment and international collaboration is confronted by complicated and internationally inconsistent regulations and the highest technical standards for any product yet produced. To cap it all, the law is quickly outpaced by technological developments and studded with ethical issues.
 
Our service

We have a distinct, comprehensive and highly focused regenerative medicine practice with a level of understanding and commitment to the area that is simply unparalleled, with the legal skills to match. We specifically focus on the commercial and clinical deployment of stem cell and related technologies and on the needs of the research community. In many cases, we know the players personally.

Intellectual property
Besides having a sound and up-to-date grasp of the science and technology of regenerative medicine, we are particularly familiar with the international patent landscape and the strategic threats and opportunities that it presents.

• our contentious patent team is specifically prepared and equipped to resolve stem cell infringement and revocation disputes. We know about certain legal problems that lie in the way and are prepared to fight, when and at whatever level necessary, to resolve them
• our non-contentious IP team already knows the likely issues in your collaboration and licence agreements and can offer early advice to help save you money. We can also find other, non-patent related means of boosting the IP value of technology innovations such as scaffolds and matrices
• our practice only works with patent attorneys who are specialists in stem cell patenting

Regulation
Whilst working with us, you can focus on your organisational objectives while we deal with the red tape. For example, we know the rules on ATMPs, cells and tissues inside out and one of our lawyers sits on behalf of interested parties at the Committee for Advanced Therapies of the EMEA. 

Our experience

Our team has more experience of cell and tissue law than any other law firm in Europe. In the United Kingdom, for example, we act for two highly relevant government regulators and are ranked in the top tiers of the legal directories for public regulatory law. We have advised on some of the most significant stem cell related matters in recent years, breaking new legal ground as our clients, private and public, pioneer new treatments and assays.

Although the cell, tissue and patent laws of different European states are largely harmonised, there are significant exceptions. Because we’re a fully-integrated European firm, we understand this patchwork, its challenges and the opportunities within it particularly well.